How Deodorant That Stops Sweating Works
Antiperspirants reduce sweat by temporarily blocking sweat glands. The active ingredient in most clinical-strength formulas is aluminum-based, typically aluminum chloride or aluminum chlorohydrate, which forms a temporary gel plug in the sweat duct. According to the FDA, antiperspirants are classified as over-the-counter drugs because they affect a body function, and they must list their active ingredients on the label. Products labeled as deodorant that stops sweating usually combine aluminum compounds with emollients and fragrances to reduce moisture and odor simultaneously.
The effectiveness depends on concentration and formulation. Standard drugstore products contain 10 to 15 percent aluminum salts, while clinical and prescription variants can reach 20 to 30 percent. A 2023 market analysis by Grand View Research noted that the global antiperspirant market was valued at approximately 28 billion USD and is projected to grow at a compound annual growth rate of around 5 percent through the next several years, driven by demand for sweat-control products. For regulatory background on how the FDA oversees these drug-cosmetic combinations, see the agency's OTC monograph guidance on external analgesics and antiperspirants FDA OTC Drug Facts.
Leading Brands and Clinical Formulations
Several brands dominate the deodorant that stops sweating segment. Certain Dri, Certain Dri Prescription Strength, and Dove Clinical Protection are frequently cited in consumer testing for high wetness protection. Certain Dri, which markets itself as a clinical antiperspirant, uses a higher concentration of aluminum chloride to target excessive underarm sweating and is available without a prescription in the United States. Dove Clinical Protection, launched in the 2010s, uses aluminum zirconium compounds and is positioned as a beauty-care antiperspirant with a focus on skin care benefits alongside sweat reduction.
Consumer Reports and similar testing organizations regularly evaluate wetness protection and odor control. In recent roundups, Certain Dri and Dove Clinical Protection have appeared among top-rated products for sustained sweat reduction. The American Academy of Dermatology notes that for people with hyperhidrosis, prescription antiperspirants containing higher aluminum chloride concentrations can be an effective first-line treatment, and consumers should consult a dermatologist if over-the-counter options fail. For a broader look at product performance and testing methodology, see Consumer Reports' antiperspirant ratings Consumer Reports Antiperspirant Ratings.
Market, Regulation, and Safety Considerations
The U.S. antiperspirant market is concentrated among a few large consumer goods companies, including Unilever, which owns Dove, and Henkel, which markets Certain Dri and Degree. Industry data from Euromonitor International shows that the deodorant and antiperspirant category in the United States generated retail sales exceeding 3 billion USD in recent years, with clinical and prescription-strength segments growing faster than standard formulations. Regulatory oversight falls under the FDA's Center for Drug Evaluation and Research, which requires antiperspirant products to meet safety and efficacy standards for OTC drugs, including labeling and ingredient limits.
Safety reviews by regulatory bodies, including the FDA and the European Commission's Scientific Committee on Consumer Safety, have concluded that aluminum-based antiperspirants are safe for consumer use at approved concentrations. Some consumers seek aluminum-free alternatives, but these products typically function as deodorants rather than antiperspirants and do not stop sweating in the same clinical sense. For a detailed overview of FDA regulatory requirements for OTC antiperspirants, see the agency's guidance on drug products FDA Guidance Documents.